{"count":221303,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1926","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1924","results":[{"created":"2020-02-17T13:18:11.523809+11:00","panel_name":"Cataract","panel_id":66,"panel_version":"0.17","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: INTS1 were set to ","entity_name":"INTS1","entity_type":"gene"},{"created":"2020-02-17T13:17:48.710156+11:00","panel_name":"Cataract","panel_id":66,"panel_version":"0.16","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: INTS1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"INTS1","entity_type":"gene"},{"created":"2020-02-17T13:17:20.411034+11:00","panel_name":"Cataract","panel_id":66,"panel_version":"0.15","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: INTS1: Rating: GREEN; Mode of pathogenicity: None; Publications: 28542170, 30622326, 31428919; Phenotypes: Neurodevelopmental disorder with cataracts, poor growth, and dysmorphic facies, MIM# 618571; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"INTS1","entity_type":"gene"},{"created":"2020-02-17T13:14:11.323449+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2194","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: INTS1 as ready","entity_name":"INTS1","entity_type":"gene"},{"created":"2020-02-17T13:14:11.314360+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2194","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ints1 has been classified as Green List (High Evidence).","entity_name":"INTS1","entity_type":"gene"},{"created":"2020-02-17T13:14:02.338190+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2194","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: INTS1 were changed from  to Neurodevelopmental disorder with cataracts, poor growth, and dysmorphic facies, MIM# 618571","entity_name":"INTS1","entity_type":"gene"},{"created":"2020-02-17T13:13:26.382518+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2193","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: INTS1 were set to ","entity_name":"INTS1","entity_type":"gene"},{"created":"2020-02-17T13:13:00.432094+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2192","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: INTS1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"INTS1","entity_type":"gene"},{"created":"2020-02-17T13:12:12.013816+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1374","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: UGT1A4 as ready","entity_name":"UGT1A4","entity_type":"gene"},{"created":"2020-02-17T13:12:12.009495+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1374","user_name":"Zornitza Stark","item_type":"entity","text":"Added comment: Comment when marking as ready: Agree, no evidence currently for Mendelian gene-disease association.","entity_name":"UGT1A4","entity_type":"gene"},{"created":"2020-02-17T13:12:11.979113+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1374","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ugt1a4 has been classified as Red List (Low Evidence).","entity_name":"UGT1A4","entity_type":"gene"},{"created":"2020-02-17T13:11:42.826051+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1374","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: UGT1A4 as Red List (low evidence)","entity_name":"UGT1A4","entity_type":"gene"},{"created":"2020-02-17T13:11:42.812822+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1374","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ugt1a4 has been classified as Red List (Low Evidence).","entity_name":"UGT1A4","entity_type":"gene"},{"created":"2020-02-17T12:41:48.667984+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1373","user_name":"Teresa Zhao","item_type":"entity","text":"reviewed gene: CHD2: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Epileptic encephalopathy, childhood-onset (MIM # 615369); Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted; Current diagnostic: yes","entity_name":"CHD2","entity_type":"gene"},{"created":"2020-02-17T11:45:00.091711+11:00","panel_name":"Incidentalome","panel_id":126,"panel_version":"0.9","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: DDX41 as ready","entity_name":"DDX41","entity_type":"gene"},{"created":"2020-02-17T11:45:00.078469+11:00","panel_name":"Incidentalome","panel_id":126,"panel_version":"0.9","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ddx41 has been classified as Green List (High Evidence).","entity_name":"DDX41","entity_type":"gene"},{"created":"2020-02-17T11:44:12.214200+11:00","panel_name":"Incidentalome","panel_id":126,"panel_version":"0.9","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: DDX41 as Green List (high evidence)","entity_name":"DDX41","entity_type":"gene"},{"created":"2020-02-17T11:44:12.200461+11:00","panel_name":"Incidentalome","panel_id":126,"panel_version":"0.9","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ddx41 has been classified as Green List (High Evidence).","entity_name":"DDX41","entity_type":"gene"},{"created":"2020-02-17T11:41:39.329647+11:00","panel_name":"Incidentalome","panel_id":126,"panel_version":"0.8","user_name":"Zornitza Stark","item_type":"entity","text":"gene: DDX41 was added\ngene: DDX41 was added to Incidentalome. Sources: Expert list\nMode of inheritance for gene: DDX41 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted\nPhenotypes for gene: DDX41 were set to {Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to} MIM#\t616871\nReview for gene: DDX41 was set to GREEN\nAdded comment: Adult-onset disorder, often initially presents with myelodysplasia +/- a range of haematological malignancies. Reduced penetrance. \nSources: Expert list","entity_name":"DDX41","entity_type":"gene"},{"created":"2020-02-17T11:35:33.259677+11:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.25","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: DDX41 as ready","entity_name":"DDX41","entity_type":"gene"},{"created":"2020-02-17T11:35:33.246131+11:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.25","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ddx41 has been classified as Green List (High Evidence).","entity_name":"DDX41","entity_type":"gene"},{"created":"2020-02-17T11:34:39.897738+11:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.25","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: DDX41 as Green List (high evidence)","entity_name":"DDX41","entity_type":"gene"},{"created":"2020-02-17T11:34:39.888555+11:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.25","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ddx41 has been classified as Green List (High Evidence).","entity_name":"DDX41","entity_type":"gene"},{"created":"2020-02-17T11:33:13.670892+11:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"gene: DDX41 was added\ngene: DDX41 was added to Bone Marrow Failure. Sources: Expert list\nMode of inheritance for gene: DDX41 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted\nPhenotypes for gene: DDX41 were set to {Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to} MIM#\t616871\nReview for gene: DDX41 was set to GREEN\nAdded comment: Adult-onset disorder, often initially presents with myelodysplasia +/- a range of haematological malignancies. Reduced penetrance. \nSources: Expert list","entity_name":"DDX41","entity_type":"gene"},{"created":"2020-02-17T11:07:58.630720+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2191","user_name":"Chern Lim","item_type":"entity","text":"reviewed gene: INTS1: Rating: GREEN; Mode of pathogenicity: None; Publications: 28542170, 30622326, 31428919; Phenotypes: Neurodevelopmental disorder with cataracts, poor growth, and dysmorphic facies, MIM# 618571; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"INTS1","entity_type":"gene"},{"created":"2020-02-17T10:12:48.433951+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1373","user_name":"Belinda Chong","item_type":"entity","text":"reviewed gene: UGT1A4: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: ; Mode of inheritance: None","entity_name":"UGT1A4","entity_type":"gene"},{"created":"2020-02-16T18:06:00.056229+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2191","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: SEMA3E as Amber List (moderate evidence)","entity_name":"SEMA3E","entity_type":"gene"},{"created":"2020-02-16T18:06:00.043217+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2191","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: sema3e has been classified as Amber List (Moderate Evidence).","entity_name":"SEMA3E","entity_type":"gene"},{"created":"2020-02-16T17:13:08.294135+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2190","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: SACS as ready","entity_name":"SACS","entity_type":"gene"},{"created":"2020-02-16T17:13:08.284824+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2190","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: sacs has been classified as Amber List (Moderate Evidence).","entity_name":"SACS","entity_type":"gene"},{"created":"2020-02-16T17:12:56.843039+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2190","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: SACS were changed from  to Spastic ataxia, Charlevoix-Saguenay type, MIM# 270550","entity_name":"SACS","entity_type":"gene"},{"created":"2020-02-16T17:12:30.968433+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2189","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: SACS were set to ","entity_name":"SACS","entity_type":"gene"},{"created":"2020-02-16T17:11:57.228944+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2188","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: SACS was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"SACS","entity_type":"gene"},{"created":"2020-02-16T17:11:27.266699+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2187","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: SACS as Amber List (moderate evidence)","entity_name":"SACS","entity_type":"gene"},{"created":"2020-02-16T17:11:27.253856+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2187","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: sacs has been classified as Amber List (Moderate Evidence).","entity_name":"SACS","entity_type":"gene"},{"created":"2020-02-16T17:10:48.844592+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2186","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: SACS: Rating: AMBER; Mode of pathogenicity: None; Publications: 28843771, 20876471, 28658676, 27871429; Phenotypes: Spastic ataxia, Charlevoix-Saguenay type, MIM# 270550; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"SACS","entity_type":"gene"},{"created":"2020-02-15T08:33:24.903924+11:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.9","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: SOX3 as ready","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:33:24.895422+11:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.9","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: sox3 has been classified as Amber List (Moderate Evidence).","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:33:18.591133+11:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.9","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: SOX3 as Amber List (moderate evidence)","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:33:18.578211+11:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.9","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: sox3 has been classified as Amber List (Moderate Evidence).","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:32:49.218808+11:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.8","user_name":"Zornitza Stark","item_type":"entity","text":"gene: SOX3 was added\ngene: SOX3 was added to Disorders of Sex Differentiation. Sources: Expert Review\nSV/CNV tags were added to gene: SOX3.\nMode of inheritance for gene: SOX3 was set to Other\nPublications for gene: SOX3 were set to 21183788; 22678921; 25781358; 31523625\nPhenotypes for gene: SOX3 were set to XX male sex reversal\nMode of pathogenicity for gene: SOX3 was set to Other\nReview for gene: SOX3 was set to AMBER\nAdded comment: Multiple individuals reported; animal model: association is with structural variants, primarily duplications. \nSources: Expert Review","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:28:17.028606+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1373","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: SOX3 were changed from Mental retardation, X-linked, with isolated growth hormone deficiency, MIM#300123; Panhypopituitarism, X-linked, MIM#312000 to Mental retardation, X-linked, with isolated growth hormone deficiency, MIM#300123; Panhypopituitarism, X-linked, MIM#312000; XX male sex reversal","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:27:41.611254+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1372","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: SOX3: Changed phenotypes: Mental retardation, X-linked, with isolated growth hormone deficiency, MIM#300123, Panhypopituitarism, X-linked, MIM#312000, XX male sex reversal","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:18:06.273798+11:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.82","user_name":"Zornitza Stark","item_type":"entity","text":"Tag SV/CNV tag was added to gene: SOX3.","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:17:28.116604+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1372","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: SOX3 as ready","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:17:28.107981+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1372","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: sox3 has been classified as Amber List (Moderate Evidence).","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:17:11.243459+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1372","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: SOX3 were changed from  to Mental retardation, X-linked, with isolated growth hormone deficiency, MIM#300123; Panhypopituitarism, X-linked, MIM#312000","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:16:47.256196+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1371","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: SOX3 were set to ","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:16:24.838815+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1370","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: SOX3 was changed from Unknown to X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:16:04.808140+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1369","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: SOX3 as Amber List (moderate evidence)","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:16:04.794778+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1369","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: sox3 has been classified as Amber List (Moderate Evidence).","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:15:44.344012+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1368","user_name":"Zornitza Stark","item_type":"entity","text":"Tag SV/CNV tag was added to gene: SOX3.","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:15:28.765070+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1368","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: SOX3: Rating: AMBER; Mode of pathogenicity: None; Publications: 29175558, 30125608, 12428212, 15800844; Phenotypes: Mental retardation, X-linked, with isolated growth hormone deficiency, MIM#300123, Panhypopituitarism, X-linked, MIM#312000; Mode of inheritance: X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:14:28.631523+11:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.82","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: SOX3 as ready","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:14:28.622370+11:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.82","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: sox3 has been classified as Red List (Low Evidence).","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:14:22.073050+11:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.82","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: SOX3 were changed from  to Mental retardation, X-linked, with isolated growth hormone deficiency, MIM#300123; Panhypopituitarism, X-linked, MIM#312000","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:13:59.039342+11:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.81","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: SOX3 were set to ","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:13:25.359708+11:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.80","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: SOX3 was changed from Unknown to X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:12:57.986841+11:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.79","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: SOX3 as Red List (low evidence)","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:12:57.975852+11:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.79","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: sox3 has been classified as Red List (Low Evidence).","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:12:28.807469+11:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.78","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: SOX3: Rating: RED; Mode of pathogenicity: None; Publications: 29175558, 30125608, 12428212, 15800844; Phenotypes: Mental retardation, X-linked, with isolated growth hormone deficiency, MIM#300123, Panhypopituitarism, X-linked, MIM#312000; Mode of inheritance: X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:10:27.597993+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2186","user_name":"Zornitza Stark","item_type":"entity","text":"Tag SV/CNV tag was added to gene: SOX3.","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:08:46.757945+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2186","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: SOX3 as ready","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:08:46.744421+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2186","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: sox3 has been classified as Amber List (Moderate Evidence).","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:08:35.956421+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2186","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: SOX3 were changed from  to Mental retardation, X-linked, with isolated growth hormone deficiency, MIM#300123; Panhypopituitarism, X-linked, MIM#312000","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:07:58.672048+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2185","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: SOX3 were set to ","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:07:23.358612+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2184","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of pathogenicity for gene: SOX3 was changed from  to Other","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:06:50.951285+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2183","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: SOX3 was changed from Unknown to X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:06:24.554603+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2182","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: SOX3 as Amber List (moderate evidence)","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:06:24.541200+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2182","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: sox3 has been classified as Amber List (Moderate Evidence).","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:05:44.421002+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2181","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: SOX3: Changed rating: AMBER","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-15T08:03:15.050619+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2181","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: SOX3: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Mental retardation, X-linked, with isolated growth hormone deficiency, MIM# 300123; Mode of inheritance: X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"SOX3","entity_type":"gene"},{"created":"2020-02-14T22:14:13.732270+11:00","panel_name":"Macrocephaly_Megalencephaly","panel_id":135,"panel_version":"0.23","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: AKT1 as ready","entity_name":"AKT1","entity_type":"gene"},{"created":"2020-02-14T22:14:13.718688+11:00","panel_name":"Macrocephaly_Megalencephaly","panel_id":135,"panel_version":"0.23","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: akt1 has been classified as Amber List (Moderate Evidence).","entity_name":"AKT1","entity_type":"gene"},{"created":"2020-02-14T22:14:06.707428+11:00","panel_name":"Macrocephaly_Megalencephaly","panel_id":135,"panel_version":"0.23","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: AKT1 were changed from Cowden syndrome 6, MIM#615109 to Cowden syndrome 6, MIM#615109","entity_name":"AKT1","entity_type":"gene"},{"created":"2020-02-14T22:13:46.320524+11:00","panel_name":"Macrocephaly_Megalencephaly","panel_id":135,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: AKT1 were changed from  to Cowden syndrome 6, MIM#615109","entity_name":"AKT1","entity_type":"gene"},{"created":"2020-02-14T22:13:26.281338+11:00","panel_name":"Macrocephaly_Megalencephaly","panel_id":135,"panel_version":"0.21","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: AKT1 were set to 23246288","entity_name":"AKT1","entity_type":"gene"},{"created":"2020-02-14T22:13:06.932689+11:00","panel_name":"Macrocephaly_Megalencephaly","panel_id":135,"panel_version":"0.21","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: AKT1 were set to ","entity_name":"AKT1","entity_type":"gene"},{"created":"2020-02-14T22:12:47.833225+11:00","panel_name":"Macrocephaly_Megalencephaly","panel_id":135,"panel_version":"0.20","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of pathogenicity for gene: AKT1 was changed from  to Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments","entity_name":"AKT1","entity_type":"gene"},{"created":"2020-02-14T22:12:28.660318+11:00","panel_name":"Macrocephaly_Megalencephaly","panel_id":135,"panel_version":"0.20","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: AKT1 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"AKT1","entity_type":"gene"},{"created":"2020-02-14T22:12:01.200056+11:00","panel_name":"Macrocephaly_Megalencephaly","panel_id":135,"panel_version":"0.19","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: AKT1 as Amber List (moderate evidence)","entity_name":"AKT1","entity_type":"gene"},{"created":"2020-02-14T22:12:01.190655+11:00","panel_name":"Macrocephaly_Megalencephaly","panel_id":135,"panel_version":"0.19","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: akt1 has been classified as Amber List (Moderate Evidence).","entity_name":"AKT1","entity_type":"gene"},{"created":"2020-02-14T22:11:33.408312+11:00","panel_name":"Macrocephaly_Megalencephaly","panel_id":135,"panel_version":"0.18","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: AKT1: Rating: AMBER; Mode of pathogenicity: Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments; Publications: 23246288; Phenotypes: Cowden syndrome 6, MIM#615109; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"AKT1","entity_type":"gene"},{"created":"2020-02-14T22:09:48.460875+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1368","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: AKT1 as ready","entity_name":"AKT1","entity_type":"gene"},{"created":"2020-02-14T22:09:48.450664+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1368","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: akt1 has been classified as Amber List (Moderate Evidence).","entity_name":"AKT1","entity_type":"gene"},{"created":"2020-02-14T22:09:33.537619+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1368","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: AKT1 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"AKT1","entity_type":"gene"},{"created":"2020-02-14T22:09:14.166165+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1367","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: AKT1 were changed from  to Cowden syndrome 6, MIM#615109; Proteus syndrome, MIM#176920","entity_name":"AKT1","entity_type":"gene"},{"created":"2020-02-14T22:08:11.572030+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1366","user_name":"Zornitza Stark","item_type":"entity","text":"Tag somatic tag was added to gene: AKT1.","entity_name":"AKT1","entity_type":"gene"},{"created":"2020-02-14T22:07:34.010710+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1366","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: AKT1 were set to ","entity_name":"AKT1","entity_type":"gene"},{"created":"2020-02-14T22:07:16.917433+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1365","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of pathogenicity for gene: AKT1 was changed from  to Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments","entity_name":"AKT1","entity_type":"gene"},{"created":"2020-02-14T22:06:00.894818+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1364","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: AKT1 as Amber List (moderate evidence)","entity_name":"AKT1","entity_type":"gene"},{"created":"2020-02-14T22:06:00.885992+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1364","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: akt1 has been classified as Amber List (Moderate Evidence).","entity_name":"AKT1","entity_type":"gene"},{"created":"2020-02-14T22:05:06.375572+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1363","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: PEX6 as ready","entity_name":"PEX6","entity_type":"gene"},{"created":"2020-02-14T22:05:06.362290+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1363","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: pex6 has been classified as Green List (High Evidence).","entity_name":"PEX6","entity_type":"gene"},{"created":"2020-02-14T22:04:49.198936+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1363","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: PEX6 were changed from  to Heimler syndrome 2, MIM#\t616617; Peroxisome biogenesis disorder 4A (Zellweger), MIM#\t614862; Peroxisome biogenesis disorder 4B, MIM#\t614863","entity_name":"PEX6","entity_type":"gene"},{"created":"2020-02-14T22:03:47.002469+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1362","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: PEX6 was changed from Unknown to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"PEX6","entity_type":"gene"},{"created":"2020-02-14T22:01:55.847329+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2181","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: PUF60 as ready","entity_name":"PUF60","entity_type":"gene"},{"created":"2020-02-14T22:01:55.833081+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2181","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: puf60 has been classified as Green List (High Evidence).","entity_name":"PUF60","entity_type":"gene"},{"created":"2020-02-14T22:01:50.369743+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2181","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: PUF60 were changed from  to Verheij syndrome, MIM# 615583","entity_name":"PUF60","entity_type":"gene"},{"created":"2020-02-14T22:01:16.384418+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2180","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: PUF60 were set to ","entity_name":"PUF60","entity_type":"gene"}]}